PHAIR Consortium

🎄 Pancreas 2023 Wrapped! 🍾 🔟 October 2023: The use of radiomics 🤖 in pancreas surgery... future or present?! 🧐 Is radiomics already impacting your clinical practice? 🫵 This is the first tool to predict the risk of POPF 🐳

The first ever Radiomics 👾 preoperative fistula risk score !!! Development 🇳🇱 and external validation 🇮🇹 🐳 The radiomics-based preop FRS performed similarly to the existing scores ( ROC 0.8) 💪 Great added value considering only CT derived data! academic.oup.com/bjsopen/articl…

Now in @BjsOpen! Externally valid #radiomics pre-op fistula risk score (RAD-FRS) for Whipple! 🇮🇹🇳🇱 FIRST externally valid model ✅ Similar AUC (0.81) to (ua)FRS (0.79) in preop setting 📷 👏 @EwoutIngwersen, @JackieBereska and @PHAIRconsortium! academic.oup.com/bjsopen/articl…

Last week radiogist Håvard Bjørke Jenssen from 🇳🇴@Oslounivsykehus visited the 🇳🇱 @AmsterdamUMC HPB team! Sharing and aligning HPB CT segmentation ✍️ strategies with Yung Nio, @JackieBereska @i_verpalen and others! 📸 Visit finalized with the annual @AmsterdamUMC HPB BBQ!

This week 🇳🇱 @i_verpalen @JackieBereska etc. from @amsterdamumc visit 🇳🇴@AAFretland @knutjla in the @Oslounivsykehus! External validation of a CRLM CT segmentation model! 📸 Discussions on imaging-based response evaluation to neoadjuvant therapy in both liver and pancreas! 💉

📢: @albe_balduzzi @BorisJanssen and @PHAIRconsortium in @BJSurgery 📈 12 imaging-based AI models to predict malignancy of IPMN 📊 Methodologically suboptimal 🔎 Methodologically robust prospective studies incl. non-surgical patients required! Read: academic.oup.com/bjs/advance-ar…

The future of IPMN management 🍇 will be based on two pillars 🏛️ Biomarkers and AI 🤖 Twelve AI based models to assess the risk of malignancy already exist! 😢 Methodological quality and reliability still to be improved… let’s work on it!! 🆓 read 👉academic.oup.com/bjs/advance-ar…

RT @MarcBesselink: Can #AI based models predict the risk of #PancreaticCancer in #IPMN? ⬇️ Scoping review @BJSurgery @PHAIRconsortium op…

@EurPancClub #EPC2023 @BorisJanssen on behalf of @PHAIRconsortium! AI residual cancer burden (RCB) to evaluate impact of NAT in resected pancreatic cancer! RCB 🔬 NAT vs. upfront: 2.2 vs. 10.3 mm2 p<0.0001 Survival 📈 Above vs. below median RCB: 24 vs. 30 months. p=0.018

@EsgarSociety #esgar2023 @PHAIRconsortium lead @i_verpalen presents: 🎙️ #ArtificialIntelligence based Assessment of Vascular Involvement and Resectability 🔪on CT in patients with PDAC Segmentation 📸 below! Great work @JackieBereska @BorisJanssen and @PHAIRconsortium ❗️

Now @EsgarSociety #ESGAR2023 Externally valid #radiomics preoperative fistula risk score (RAD-FRS) for Whipple! FIRST externally valid model of its kind ✅ Similar AUC (0.81) to (ua)FRS (0.79) in preop setting ✅ Great work @EwoutIngwersen, @JackieBereska and @PHAIRconsortium!

#EAHPBA2023 @EAHPBA Segmentation model for 🔬 residual pancreatic cancer following neoadjuvant therapy (ISGPP-2)! Model based on 528 pt, 14 centers, 7 countries🇳🇱🇺🇸🇩🇪🇳🇴🇹🇷🇰🇷🇦🇺, 4 scanner types! Validated with by-scanner internal-external cross-validation 📊! F1 score of 0.78!

#EAHPBA2023 @EAHPBA External validation of #radiomics preoperative fistula💧 risk score (RAD-FRS) for Whipple 🔪 ! FIRST externally validated model of its kind ✅ Similar AUC to (ua)FRS in pre-op setting ✅ Great work by @EwoutIngwersen, @JackieBereska and @PHAIRconsortium!